Concepts for 18/30 GHz satellite communication system study. Executive summary

An examination of a multiplicity of interconnected parameters ranging from specific technology details to total system economic costs for satellite communication systems at the 18/30 GHz transmission bands are presented. It was determined that K sub A band systems can incur a small communications outage during very heavy rainfall periods and that reducing the outage to zero would lead to prohibitive system costs. On the other hand, the economics of scale, ie, one spacecraft accommodating 2.5 GHz of bandwidth coupled with multiple beam frequency reuse, leads to very low costs for those users who can tolerate the 5 to 50 hours per year of downtime. A multiple frequency band satellite network can provide the ultimate optimized match to the consumer performance/economics demands

Study of efficient transmission and reception of image-type data using millimeter waves

Evaluation of signal processing and modulation techniques for transmission and reception of image type data via millimeter wave relay satellite

Television broadcast from space systems: Technology, costs

Broadcast satellite systems are described. The technologies which are unique to both high power broadcast satellites and small TV receive-only earth terminals are also described. A cost assessment of both space and earth segments is included and appendices present both a computer model for satellite cost and the pertinent reported experience with the Japanese BSE

Concepts for 18/30 GHz satellite communication system, volume 1

Concepts for 18/30 GHz satellite communication systems are presented. Major terminal trunking as well as direct-to-user configurations were evaluated. Critical technologies in support of millimeter wave satellite communications were determined

Concepts for 18/30 GHz satellite communication system, volume 1A: Appendix

The following are appended: (1) Propagation phenomena and attenuation models; (2) Models and measurements of rainfall patterns in the U.S.; (3) Millimeter wave propagation experiments; (4) Comparison of the theory and Millimeter wave propagation experiments; (4) Comparison of theory and experiment; (5) A practical rain attenuation model for CONUS; (6) Space diversity; (7) Values of attenuation for selected U.S. cities; and (8) Additional considerations

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major

Transfusion and iron chelation treatment have significantly reduced morbidity and improved survival of patients with thalassemia major. However, cardiac disease continues to be the most common cause of death. We report the left-ventricular ejection fraction, determined by echocardiography, in one hundred sixtyeight patients with thalassemia major followed for at least 5 years who received continuous monotherapy with deferoxamine (N = 108) or deferiprone (N = 60). The statistical analysis, using the generalized estimating equations model, indicated that the group treated with deferiprone had a significantly better left-ventricular ejection fraction than did those treated with deferoxamine (coefficient 0.97; 95% CI 0.37; 1.6, p = 0.002). The heart may be particularly sensitive to iron-induced mitochondrial damage because of the large number of mitochondria and its low level of antioxidants. Deferiprone, because of its lower molecular weight, might cross into heart mitochondria more efficiently, improving their activity and, thereby, myocardial cell function. Our findings indicate that the long-term administration of deferiprone significantly enhances left-ventricular function over time in comparison with deferoxamine treatment. However, because of limitations related to the design of this study, these findings should be confirmed in a prospective, randomized clinical trial

Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.

Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric retrospective analysis of liver disease in a cohort of 191 transfusion-dependent thalassemics, in 126 patients who had undergone liver biopsy (mean age 17.2 years; 58 hepatitis virus C-RNA positive and 68 hepatitis virus C-RNA negative) the liver iron concentration (median 2.4 mg/gr dry liver weight) was closely related to serum ferritin levels (R = 0.58; p<0.0001). Male gender (OR 4.12) and serum hepatitis virus C-RNA positivity (OR 11.04) were independent risk factors for advanced liver fibrosis. The majority of hepatitis virus C-RNA negative patients with low iron load did not develop liver fibrosis, while hepatitis virus C-RNA positive patients infected with genotype 1 or 4 and iron overload more frequently developed advanced fibrosis. Hepatitis virus C infection is the main risk factor for liver fibrosis in transfusion-dependent thalassemics. Adequate chelation therapy usually prevents the development of liver fibrosis in thalassemics free of hepatitis virus C-infection and reduces the risk of developing severe fibrosis in thalassemics with chronic hepatitis C

Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death

Cardiac damage remains a major cause of mortality among patients with thalassemia major. The detection of a lower cardiac magnetic resonance T2* (CMR-T2*) signal has been suggested as a powerful predictor of the subsequent development of heart failure. However, the lack of worldwide availability of CMR-T2* facilities prevents its widespread use for follow-up evaluations of cardiac function in thalassemia major patients, warranting the need to assess the utility of other possible procedures.In this setting,the determination of left ventricular ejection fraction (LVEF)offers an accurate and reproducible method for heart function evaluation. These findings suggest a reduction in LVEF≥7%, over time, determined by 2-D echocardiography, may be considered a strong predictive tool for the detection of thalassemia major patients with increased risk of cardiac death. The reduction of LVEF≥7% had higher (84.76%) predictive value. Finally, Kaplan–Meier survival curves of thalassemia major patients with LVEF≥7% showed a statistically significant decreased probability of survival for heart disease (p=0.0022). However, because of limitations related to the study design, such findings should be confirmed in a large long-term prospective clinical trial